Simon Papillon-Cavanagh

5PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 23, 2022
Pan-cancer analysis of the effect of biopsy site on tumor mutational burden observations.

Simon Papillon-Cavanagh, Julia F Hopkins, Shakti H Ramkissoon

|Mar 19, 2022
Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma.

Robert J Motzer, Toni K Choueiri, David F McDermott

|Mar 04, 2021
Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC.

Petra Ross-Macdonald, Alice M Walsh, Scott D Chasalow

|Apr 11, 2017
Spatial heterogeneity in medulloblastoma.

A Sorana Morrissy, Florence M G Cavalli, Marc Remke

|Jan 10, 2017
Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas.

Simon Papillon-Cavanagh, Chao Lu, Tenzin Gayden

Pageof 1